SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $333 | -99.9% | 2,568 | -46.0% | 0.22% | -33.0% |
| Q1 2022 | $372,000 | -8.1% | 4,752 | +5.7% | 0.34% | -42.2% |
| Q4 2021 | $405,000 | +289.4% | 4,496 | +502.7% | 0.58% | +453.3% |
| Q3 2020 | $104,000 | -85.0% | 746 | -83.7% | 0.10% | -59.9% |
| Q2 2020 | $694,000 | +298.9% | 4,565 | +156.0% | 0.26% | -7.4% |
| Q1 2020 | $174,000 | -74.9% | 1,783 | -60.9% | 0.28% | -27.6% |
| Q2 2019 | $694,000 | – | 4,565 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |